XTLBNasdaqPharmaceutical Preparations
XTL BIOPHARMACEUTICALS LTD
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Jun 30, 2026
$1.96−0.00 (-0.01%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Xtl Biopharmaceuticals has not reported a dividend
No dividend per share appears in Xtl Biopharmaceuticals's annual filings since fiscal 2014.